Cambridge Enterprise Limited takes 6.7% stake in Dropcode Bio, biotech data firm
Published
Cambridge Enterprise Limited entered the register with 9,989 ordinary shares, giving it a 6.7% stake in the biotech data firm. Existing holders FoodLabs Fund III GmbH & Co. KG and J12 Ventures Nordic II AB also increased their holdings with Pre-Seed 2 preferred shares. Filed on 8 September 2026, the statement covers the period from 3 September 2025 to 3 September 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | CAMBRIDGE ENTERPRISE LIMITED | 9,989 | — | ORDINARY 9,989 |
| Increased | FOODLABS FUND III GMBH & CO. KG | 26,483 | +36% | PRE-SEED 1 PREFERRED 19,516 PRE-SEED 2 PREFERRED 6,967 |
Current shareholders (6)
| Shareholder | Total shares | Share classes |
|---|---|---|
| FOODLABS FUND III GMBH & CO. KG | 26,483 | PRE-SEED 1 PREFERRED 19,516 PRE-SEED 2 PREFERRED 6,967 |
| J12 VENTURES NORDIC II AB | 19,938 | ORDINARY 17,291 PRE-SEED 1 PREFERRED 1,951 PRE-SEED 2 PREFERRED 696 |
| CAMBRIDGE ENTERPRISE LIMITED | 9,989 | ORDINARY 9,989 |
| HALO II PCC LIMITED ACTING IN RESPECT OF HALO II PCC SUB CELL 40 | 1,310 | ORDINARY 1,310 |
| FORMULA TWO AB | 865 | ORDINARY 865 |
| NOFAP AB | 365 | ORDINARY 365 |
Contact the editorial team at editorial@fundingspotter.com